Conference abstract · 20 Feb 2023
Conference abstractPublished 2 Nov 2017
Design and development of ovarian cancer vaccines
The University of New Mexico, USA; Mercer University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The aim of this study was to monitor cell-based immune response developed by microparticulate ovarian cancer vaccine when administered via dissolving microneedles for transdermal routes in murine models and correlate it with tumor retardation observed in tumor challenge study. Immunotherapeutic strategies may serve as an alternative method to control the recurrence or progression of ovarian cancer. Therefore, we propose here microparticulate vaccine to treat as well as to prevent ovarian cancer. This vaccine resulted in tumor retardation when challenged with live tumor cells. Recently, we conducted a study to understand the mechanism by which the vaccine worked, where we compared humoral and cellular immune response with tumor suppression observed. We also checked the efficacy of the adjuvants to improve the efficacy of the vaccine. The microparticles were made up of cellulose polymers such as HPMC, CPD and EC. Alum and MF59 were used as adjuvants to enhance the immune response. The microneedles were formulated using polymers such as HPMCAS and PVA along with sugars such as maltose and trehalose for their dissolving properties. We have demonstrated the efficacy of vaccine microparticles containing whole cell lysate of ID8 ovarian cancer cells in retarding tumor growth in murine models. Spray drying process and the formulation used for this purpose could retain the immunogenicity of vaccine resulting in T-cell response. Thus, the microparticulate vaccine provides a promising approach in terms of cost-effectiveness, ease of production and patient compatibility.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 4 Dec 2023
Developments in Ovarian Cancer Research: Progress in Diagnosis and Treatments
Conference abstract · 15 Oct 2013
Identification of targets for the development of novel immune-based anticancer treatments in colorectal and ovarian cancer
Review article · 2015
Prostate Cancer Immunotherapy: Exploiting the HLA Class II Pathway in Vaccine Design
Mini review · 29 Dec 2023
A new era in cancer vaccine development.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Perspective · 10 Sep 2026
Cellular Pathways Involved in Mucosal Immunity and Protection Against Environmental Challenges
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Rikhav P Gala”
- BylineArticles whose byline prints “Martin J D’Souza”

